Neurogene Inc. (NGNE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$39.31M2012: -$51.10M2013: -$65.69M2014: $36.15M2015: $108.42M2016: $144.66M2017: $98.89M2018: $72.67M2019: $141.69M2020: $191.22M2021: -$91.88M2022: -$145.74M2023: $186.02M2024: $310.38M2025: $264.89M$264.89M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$264.89M-14.7%
2024$310.38M+66.8%
2023$186.02M+227.6%
2022-$145.74M-58.6%
2021-$91.88M-148.0%
2020$191.22M+35.0%
2019$141.69M+95.0%
2018$72.67M-26.5%
2017$98.89M-31.6%
2016$144.66M+33.4%
2015$108.42M+199.9%
2014$36.15M+155.0%
2013-$65.69M-28.6%
2012-$51.10M-30.0%
2011-$39.31M